Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma

Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

NCT02192359 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma

NCT02022644 ·Status: COMPLETED ·Phase: PHASE1

Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma

NCT00003616 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme

NCT00027612 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00099125 ·Status: COMPLETED ·Phase: PHASE2

Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal

NCT03696680 ·Status: RECRUITING ·Phase: PHASE2

Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma

NCT07061626 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

NCT02179086 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma

NCT01507506 ·Status: TERMINATED ·Phase: PHASE3

Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma

NCT00210314 ·Status: COMPLETED ·Phase: PHASE2

Irinotecan in Treating Patients With Recurrent Glioma

NCT00003134 ·Status: COMPLETED ·Phase: PHASE2

Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

NCT01392209 ·Status: COMPLETED ·Phase: PHASE1

Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients

NCT04998864 ·Status: COMPLETED

A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma

NCT02866747 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

NCT00431561 ·Status: COMPLETED ·Phase: PHASE2

Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors

NCT00179803 ·Status: COMPLETED ·Phase: PHASE2

ANG1005 in Patients With Recurrent High-Grade Glioma

NCT01967810 ·Status: COMPLETED ·Phase: PHASE2

Trial of IDH305 in IDH1 Mutant Grade II or III Glioma

NCT02977689 ·Status: WITHDRAWN ·Phase: PHASE2

Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma

NCT02567539 ·Status: COMPLETED ·Phase: NA

Temozolomide and Radiation Therapy in Treating Patients With Gliomas

NCT00114140 ·Status: COMPLETED ·Phase: PHASE2

Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas

NCT00053040 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.

NCT05109728 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma

NCT00283556 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Neoadjuvant Chemoradiation for Resectable Glioblastoma

NCT04209790 ·Status: TERMINATED ·Phase: PHASE2

Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I

NCT00671801 ·Status: TERMINATED ·Phase: PHASE1